➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Express Scripts
Moodys
Baxter

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Cirba Inc. v. VMware, Inc. (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Cirba Inc. v. VMware, Inc. (D. Del. 2019)

Docket   Start Trial Date Filed 2019-04-25
Court District Court, D. Delaware Date Terminated
Cause 35:1 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Parties CIRBA INC.; CIRBA IP, INC.; VMWARE, INC.
Patents 10,004,742; 10,004,745; 10,004,750; 10,010,568; 10,016,415; 10,029,011; 10,064,813; 10,085,997; 10,093,732; 10,099,996; 10,131,907; 10,143,697; 10,143,723; 10,143,731; 10,143,742; 10,143,755; 10,143,756; 10,143,905; 10,149,904; 10,155,801; 10,172,802; 10,182,591; 10,189,818; 10,189,837; 10,214,540; 10,214,590; 10,214,732; 10,244,765; 10,278,415; 10,278,920; 10,278,935; 10,342,646; 10,342,764; 10,342,813; 10,342,938; 10,351,517; 10,358,453; 10,358,653; 10,358,680; 10,376,580; 10,376,584; 10,376,587; 10,376,588; 10,376,595; 10,376,658; 10,379,975; 10,415,014; 10,456,645; 10,456,646; 10,456,653; 10,463,742; 10,492,723; 10,499,636; 10,501,773; 10,517,850; 10,519,164; 10,519,228; 10,519,252; 10,526,594; 10,526,631; 10,526,656; 10,526,657; 10,543,186; 10,543,273; 10,548,876; 10,568,568; 10,570,202; 10,584,169; 10,588,886; 10,588,975; 10,590,143; 10,590,182; 10,590,185; 10,604,806; 10,617,667; 10,617,742; 10,617,755; 10,617,756; 10,617,813; 10,618,935; 10,618,967; 10,618,971; 10,624,814; 10,624,884; 6,071,706; 6,156,372; 6,156,742; 6,231,849; 6,268,010; 6,268,343; 6,302,813; 6,302,897; 6,338,687; 6,342,657; 6,395,767; 6,468,576; 6,503,754; 6,503,894; 6,505,597; 6,544,750; 6,582,654; 6,590,078; 6,620,585; 6,638,542; 6,649,597; 6,649,905; 6,653,530; 6,656,935; 6,663,107; 6,663,517; 6,663,849; 6,663,880; 6,669,584; 6,692,367; 6,692,630; 6,692,789; 6,702,850; 6,706,681; 6,720,453; 6,730,139; 6,736,302; 6,750,019; 6,773,720; 6,774,122; 6,775,887; 6,837,907; 6,838,093; 6,838,252; 6,844,152; 6,872,397; 6,872,701; 6,905,886; 6,941,326; 6,976,647; 7,041,017; 7,060,687; 7,105,730; 7,111,730; 7,115,663; 7,115,707; 7,122,372; 7,122,592; 7,128,667; 7,128,894; 7,135,624; 7,147,779; 7,149,631; 7,157,584; 7,169,791; 7,186,732; 7,214,804; 7,217,510; 7,217,519; 7,232,818; 7,232,935; 7,241,907; 7,244,571; 7,244,591; 7,244,757; 7,261,654; 7,270,813; 7,326,708; 7,331,885; 7,351,691; 7,351,701; 7,351,813; 7,425,326; 7,427,622; 7,427,638; 7,427,698; 7,456,219; 7,465,587; 7,465,756; 7,468,372; 7,476,780; 7,491,692; 7,510,584; 7,517,519; 7,540,813; 7,541,363; 7,544,698; 7,575,526; 7,575,742; 7,582,658; 7,582,694; 7,585,897; 7,589,102; 7,589,124; 7,589,193; 7,592,167; 7,592,467; 7,593,397; 7,608,261; 7,608,723; 7,608,756; 7,618,996; 7,622,592; 7,622,632; 7,622,636; 7,622,658; 7,628,996; 7,629,342; 7,629,345; 7,637,260; 7,638,620; 7,642,268; 7,645,425; 7,645,588; 7,647,468; 7,648,698; 7,667,044; 7,667,091; 7,682,642; 7,687,060; 7,687,075; 7,691,584; 7,709,022; 7,709,517; 7,723,573; 7,732,135; 7,732,162; 7,745,571; 7,767,656; 7,767,657; 7,767,687; 7,776,838; 7,776,844; 7,807,135; 7,807,167; 7,807,370; 7,807,618; 7,807,681; 7,807,708; 7,807,804; 7,818,100; 7,850,554; 7,884,263; 7,884,264; 7,886,697; 7,887,844; 7,897,363; 7,897,585; 7,897,588; 7,897,850; 7,907,135; 7,935,121; 7,935,372; 7,935,687; 7,951,589; 7,951,766; 7,976,199; 7,976,886; 7,994,129; 8,013,113; 8,092,996; 8,101,663; 8,101,818; 8,105,618; 8,121,712; 8,128,589; 8,143,425; 8,158,590; 8,178,519; 8,178,554; 8,182,838; 8,192,756; 8,222,010; 8,241,849; 8,252,589; 8,252,776; 8,252,801; 8,252,813; 8,252,838; 8,263,647; 8,268,008; 8,268,316; 8,268,348; 8,268,791; 8,268,804; 8,273,526; 8,273,789; 8,278,492; 8,287,897; 8,287,905; 8,287,940; 8,323,692; 8,323,884; 8,324,439; 8,327,844; 8,338,100; 8,343,776; 8,367,415; 8,367,649; 8,367,657; 8,367,701; 8,367,732; 8,372,624; 8,372,872; 8,394,367; 8,394,372; 8,394,463; 8,394,765; 8,415,332; 8,415,348; 8,425,462; 8,425,880; 8,425,938; 8,460,663; 8,491,882; 8,491,940; 8,501,712; 8,501,818; 8,517,631; 8,530,498; 8,541,044; 8,545,884; 8,546,608; 8,546,645; 8,563,608; 8,563,688; 8,563,692; 8,563,698; 8,568,747; 8,574,568; 8,574,575; 8,580,323; 8,580,723; 8,580,765; 8,586,630; 8,589,182; 8,591,885; 8,591,897; 8,591,938; 8,592,149; 8,592,156; 8,592,462; 8,592,644; 8,592,649; 8,597,143; 8,597,632; 8,597,654; 8,608,698; 8,609,701; 8,609,722; 8,617,100; 8,617,543; 8,617,554; 8,617,591; 8,617,593; 8,617,594; 8,617,595; 8,617,597; 8,617,876; 8,623,591; 8,623,818; 8,623,830; 8,628,724; 8,628,754; 8,632,773; 8,636,813; 8,637,457; 8,658,573; 8,658,608; 8,663,155; 8,663,617; 8,663,628; 8,663,657; 8,663,681; 8,669,227; 8,669,290; 8,691,185; 8,691,231; 8,697,193; 8,697,618; 8,697,747; 8,708,592; 8,709,081; 8,709,107; 8,709,519; 8,722,657; 8,742,185; 8,747,894; 8,747,897; 8,754,194; 8,765,167; 8,765,169; 8,765,172; 8,765,189; 8,765,421; 8,778,302; 8,778,394; 8,778,997; 8,814,920; 8,843,356; 8,888,614; 8,935,994; 8,940,302; 8,940,330; 8,940,487; 8,940,698; 8,940,766; 8,940,780; 8,940,876; 8,951,722; 8,951,967; 8,951,994; 8,951,996; 8,975,270; 8,975,457; 9,023,401; 9,023,807; 9,034,300; 9,050,302; 9,072,813; 9,078,838; 9,079,905; 9,085,709; 9,095,706; 9,096,681; 9,096,907; 9,101,592; 9,102,742; 9,107,813; 9,107,837; 9,119,791; 9,125,804; 9,126,941; 9,145,462; 9,149,474; 9,149,707; 9,155,706; 9,155,730; 9,155,776; 9,193,732; 9,193,757; 9,193,791; 9,226,967; 9,258,997; 9,260,724; 9,284,367; 9,290,755; 9,295,657; 9,302,002; 9,345,724; 9,345,754; 9,345,773; 9,359,597; 9,370,802; 9,415,004; 9,415,009; 9,415,050; 9,421,278; 9,422,469; 9,422,593; 9,439,886; 9,439,907; 9,439,940; 9,468,585; 9,468,636; 9,468,747; 9,474,273; 9,474,706; 9,474,757; 9,474,779; 9,487,767; 9,487,773; 9,492,417; 9,492,443; 9,499,545; 9,499,622; 9,499,766; 9,499,850; 9,505,701; 9,505,722; 9,505,754; 9,510,511; 9,511,193; 9,517,241; 9,517,253; 9,523,691; 9,526,209; 9,526,623; 9,526,703; 9,526,707; 9,526,709; 9,526,710; 9,526,791; 9,526,844; 9,540,425; 9,545,379; 9,550,975; 9,554,574; 9,573,818; 9,574,010; 9,585,884; 9,585,920; 9,586,940; 9,586,994; 9,586,996; 9,592,193; 9,592,252; 9,592,253; 9,592,273; 9,597,345; 9,597,397; 9,597,571; 9,597,591; 9,617,302; 9,617,343; 9,617,574; 9,618,476; 9,622,971; 9,622,975; 9,623,087; 9,623,152; 9,623,189; 9,624,260; 9,624,295; 9,629,920; 9,630,930; 9,630,975; 9,630,976; 9,631,164; 9,631,193; 9,646,199; 9,649,209; 9,649,379; 9,649,456; 9,650,327; 9,650,589; 9,663,510; 9,663,523; 9,663,574; 9,663,778; 9,669,089; 9,669,096; 9,669,107; 9,669,108; 9,669,151; 9,681,646; 9,687,474; 9,687,517; 9,687,526; 9,687,568; 9,687,608; 9,687,609; 9,688,765; 9,694,149; 9,701,712; 9,701,747; 9,701,971; 9,707,155; 9,707,182; 9,707,302; 9,708,618; 9,724,323; 9,724,331; 9,724,343; 9,724,358; 9,724,380; 9,724,391; 9,724,395; 9,724,415; 9,724,657; 9,731,082; 9,731,169; 9,732,107; 9,732,145; 9,732,149; 9,732,326; 9,732,343; 9,745,500; 9,750,703; 9,750,747; 9,756,687; 9,756,834; 9,757,351; 9,757,394; 9,764,342; 9,765,147; 9,765,182; 9,765,351; 9,765,380; 9,775,838; 9,775,844; 9,775,849; 9,775,904; 9,789,125; 9,789,156; 9,789,185; 9,789,193; 9,789,210; 9,804,151; 9,814,722; 9,814,767; 9,814,780; 9,834,586; 9,834,646; 9,844,510; 9,844,574; 9,844,594; 9,849,164; 9,849,193; 9,849,199; 9,907,379; 9,907,756; 9,907,775; 9,907,780; 9,907,801; 9,907,802; 9,907,849; 9,938,331; 9,938,356; 9,975,894; 9,994,628; 9,994,814; 9,997,273
Attorneys Adam Adler; Anne Shea Gaza; Ariel Green; Christine E. Lehman; Courtland L. Reichman; Gary J. Toman; Jaime F Cardenas-Navia; Jennifer Estremera; Joachim B. Steinberg; Julie M.K. Siegal; Kate M. Falkenstien; Kenneth Laurence Dorsney; Khue V. Hoang; Michael G. Flanigan; Paul D. Clement; Peter J. Ayers; Richard S.J. Hung; Robert M. Vrana; Samantha G. Wilson; Sarah O. Jorgensen; Seth P. Waxman; Shawna L. Ballard; Thomas G. Saunders; Wesley Lanier White; William F. Lee; Yue Li
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Cirba Inc. v. VMware, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Cirba Inc. v. VMware, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Cirba Inc. v. VMware, Inc. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-09-27 208 Claim Construction Chart :7- 60 • ’687 …claims of U.S. Patent Nos. 8,209,687 (“the ’687 patent”) and 9,654,367 (“the ’367 patent”), respectively… Proposed Constructions for U.S. Patent No. 8,209,687 (’687 patent) Claim Term/Phrase …History of U.S. Patent No. 8,209,687, • ’687 Patent File History:….S. Patent No. 8,209,687 specification at • ’687 Patent: 2:27 External link to document
2020-01-10 479 Redacted Document 26:10-29:11 106 29:22-30:9 106 26:10-29:11 … 26:10-29:11 106 32:14-34:8 MIS, H, 106 26:10-29:11 … 26:10-29:11 106 35:8-10 26:10-29:11 37:10… 26:10-29:11; 30:12-20 H, 106 30… 29:4-29:10 29:11-29:17 External link to document
2020-04-24 720 Redacted Document different from Cirba’s patent-practicing product. (See, e.g., DTX-5328 at 9:43-10:10 (Mr. Hillier stating…the rule applies. (PTX-2057 at 98-99; see also PTX-1648 at 9-10, 12 (Compute Policies also created … DTX- 4008 at 5; TT 467:10-20, 594:25-595:8 (Densify practices ’687 patent.).) Even at the PI hearing…’367 patent’s value based solely on one customer’s purchase of Densify over vROps. (Id. 1020:10-1021…Commil USA, LLC v. Cisco Sys., Inc., 813 F.3d 994, 996-97 (Fed. Cir. 2015) (reversing JMOL denial where External link to document
2020-04-27 724 Redacted Document rel. B.B. v. Del. Coll. Preparatory Acad., No. 16-806-CFC, 2019 WL 949204, at *5 (D. Del. Feb. 27, 2019…Opposition to Cirba's Motion for Post-Trial Relief (D.I. 604) by VMware, Inc.. (Attachments: # 1 Exhibit A, # …opposition to Cirba’s Motion for Post-Trial Relief (D.I. 604). Leave should be granted because (1) Cirba’s reply…25 April 2019 1:19-cv-00742-LPS 830 Patent Plaintiff District Court, D. Delaware… agree to give Cirba 100% of its profits (id. ¶¶ 10, 20-22); and (3) asserting, for the first time, that External link to document
2020-05-01 732 Letter On August 10, 2015, each Defendant filed a motion for summary judgment on grounds of patent invalidity…infringe U.S. Patent No. 7,631,336 (“‘336 Patent”). Id. ¶ 22. The ‘336 Patent is entitled…Mill Road | Palo Alto, CA 94304-1018 P: +1 (650) 813-5689 mofo.com | LinkedIn | Twitter Case 1:19-cv…the ’367 patent); id. at 592:4-19 (skipping 27 slides related to claim 3 of the ’687 patent). Likewise…708, Exhibit A)): 5, 12, 20-21, 25-26, 49, 61-62, 64-65, 67, 69-70, 72, 78, 80- 87, External link to document
2020-05-04 736 Brief - Answering Brief in Opposition Street Boston, MA 02109 (617) 526-6000 william.lee@wilmerhale.com Case 1:19-cv-00742-LPS Document 736 Filed… 25 April 2019 1:19-cv-00742-LPS 830 Patent Plaintiff District Court,… 5 Case 1:19-cv-00742-LPS Document 736 Filed 05/04/20 Page 10 of 11 PageID #: 57929 …AND DORR LLP 60 State Street Boston, MA 02109 (617) 526-6000 william.lee@wilmerhale.com … 4 May 2020 PACER Document Case 1:19-cv-00742-LPS Document 736 Filed 05/04/20 Page 1 of 11 PageID External link to document
2020-05-08 739 Letter statements in Densify’s closing argument. (D.I. 584.) The Court summarily denied that request as well…iTV, Inc. v. Hawaiian Telecom, Inc., No. 1:14-cv-00169-ACK-RLP (D. Haw. Dec. 8, 2015), is not relevant …25 April 2019 1:19-cv-00742-LPS 830 Patent Plaintiff District Court, D. Delaware…Circuit will not “guess at what the jury saw.” 694 F.3d 10, 32 n.16 (2012). Densify met this burden by lodging…(claim construction and summary judgment), id. at 10, in part, because the only opportunity to review External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Dow
AstraZeneca
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.